Lobby organisation
Impact Europe
NGO or non-profit · Finance · HQ: Belgium · Transparency Register entry
As of 7 November 2026, Impact Europe appears in 3 declared MEP meetings (3 different MEPs), most often with Socialists & Democrats.
In their own words
“Based in Brussels, Impact Europe formed as EVPA in 2004 as a non-profit, membership association gathering organisations focused on venture philanthropy (VP) and social investment (SI). As the field evolved, EVPA has become 'Impact Europe' encompassing organisations interested in impact investing. Despite this change, Impact Europe's north start remains investing for impact, guided by intentionality, additionality, and measurability.”
Read the rest of the statementShow less of the statement
“Our mission is to enable European-based capital providers to accelerate positive and lasting social and environmental change at scale through increased resources, collaboration, expertise and facilitating an enabling policy framework. Today, we gather almost 350 members and partners from 30 countries, mainly based in Europe. Our diverse community includes social impact funds, grant-making foundations, private equity and professional service firms, financial institutions, philanthropy advisors, banks and business schools.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 3 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2026–2026. Bar length is relative to its busiest year (3 in 2026). All meetings were in one calendar year. Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 3 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 6 May 2026 | Heléne Fritzon | elektronikavfall, ETS |
| 26 Mar 2026 | Lara Wolters | SFDR revision |
| 10 Mar 2026 | Wouter Beke | How the EU can strengthen its attractiveness for long-term investment in the pharmaceutical sector, to the benefit of patients and Europe’s competitiveness |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.